| Bella Taylor, LPN | |
|
337 Mckinley St, Bristol, PA 19007-4312 | |
| (800) 950-6066 | |
| Not Available |
| Full Name | Bella Taylor |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 337 Mckinley St, Bristol, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386881506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 26NP02251200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bella Taylor, LPN 337 Mckinley St, Bristol, PA 19007-4312 Ph: (800) 950-6066 | Bella Taylor, LPN 337 Mckinley St, Bristol, PA 19007-4312 Ph: (800) 950-6066 |
News Archive
The air we exhale contains information that can assist with the diagnosis of disease. Researchers at the Fraunhofer Project Hub for Microelectronic and Optical Systems for Biomedicine MEOS are now developing solutions designed to enable the analysis of breath gas for this purpose. Although their research focuses on the early detection of cancer, the same principle could also be applied to distinguish between COVID-19 and other respiratory diseases.
SCAN Health Plan Arizona announced today that Scottsdale Healthcare joined the health plan's provider network, effective immediately.
Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer's disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. Ovarian cancer isn't typically discovered until it's in the advanced stages, where it is already spreading to other organs and is very difficult to fight with chemotherapy.
› Verified 9 days ago